Sign In
Buy RGEN
$121.73
+0.600 (+0.495%)
At Close: Jun 03, 2026
Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells
06:08pm, Sunday, 15'th Feb 2026
In the fourth quarter of 2025, the Baron Discovery Fund returned 0.19% (Institutional Shares), trailing the Russell 2000 Growth Index by 1.03%. In these periods, low quality (high debt and poor profit
Repligen (RGEN) to Release Quarterly Earnings on Thursday
04:30am, Thursday, 12'th Feb 2026
Repligen (NASDAQ: RGEN - Get Free Report) will likely be releasing its Q4 2025 results before the market opens on Thursday, February 19th. Analysts expect the company to announce earnings of $0.44 per
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results
07:30am, Tuesday, 10'th Feb 2026
Webcast and Conference Call to Be Held Tuesday, February 24, 2026, at 8:30 a.m. ET Webcast and Conference Call to Be Held Tuesday, February 24, 2026, at 8:30 a.m. ET
Bessemer Group Inc. Sells 238,450 Shares of Repligen Corporation $RGEN
04:52am, Monday, 09'th Feb 2026
Bessemer Group Inc. trimmed its stake in Repligen Corporation (NASDAQ: RGEN) by 95.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Comm
Conestoga Mid Cap Composite Q4 2025 Leaders And Laggards
10:09am, Sunday, 25'th Jan 2026
Conestoga Mid Cap Composite Q4 2025 Leaders And Laggards
Repligen Corporation (RGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
02:55am, Wednesday, 14'th Jan 2026
Repligen Corporation (RGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
07:30am, Tuesday, 06'th Jan 2026
WALTHAM, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that the Board has elected
Delta Investment Management LLC Buys Shares of 50,717 Repligen Corporation $RGEN
05:25am, Thursday, 01'st Jan 2026
Delta Investment Management LLC purchased a new position in Repligen Corporation (NASDAQ: RGEN) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange
Assenagon Asset Management S.A. Takes Position in Repligen Corporation $RGEN
03:18am, Monday, 22'nd Dec 2025
Assenagon Asset Management S.A. purchased a new position in Repligen Corporation (NASDAQ: RGEN) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commi
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference
07:30am, Thursday, 18'th Dec 2025
WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate i
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows
07:30am, Tuesday, 16'th Dec 2025
WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new h
AWM Investment Company Inc. Sells 12,000 Shares of Repligen Corporation $RGEN
03:51am, Saturday, 13'th Dec 2025
AWM Investment Company Inc. lowered its position in shares of Repligen Corporation (NASDAQ: RGEN) by 21.1% in the second quarter, according to its most recent disclosure with the SEC. The institutiona
Edgestream Partners L.P. Makes New $3.48 Million Investment in Repligen Corporation $RGEN
04:27am, Thursday, 04'th Dec 2025
Edgestream Partners L.P. purchased a new stake in Repligen Corporation (NASDAQ: RGEN) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Comm
Repligen Corporation (RGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript
04:43pm, Wednesday, 03'rd Dec 2025
Repligen Corporation (RGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript
Advisors Asset Management Inc. Cuts Holdings in Repligen Corporation $RGEN
03:16am, Monday, 01'st Dec 2025
Advisors Asset Management Inc. lowered its position in Repligen Corporation (NASDAQ: RGEN) by 20.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm
